Veterinary (Animal Drug) Drug Market : Global Demand, Growth Analysis & Opportunity Outlook 2023

Global Veterinary Drug Market Overview

Veterinary drugs have established importance in the treatment of numerous diseases growing in animals. Veterinary drugs including antibiotics and amino acids are developed in order to minimize the attack of harmful virus and bacterial parasites in animals.

Introduction of advanced cost effective veterinary drugs, rising clinical animal researches in order to treat diseases and other disorders, increases safety and effectiveness of veterinary drugs, thus swelling the demand for veterinary globally.

Increasing investments in research and development in order to develop more effective and safe veterinary drugs with fewer side effects are beneficial for the growth of veterinary drug industry.

Rising awareness towards healthcare and well-being of livestock companion and pets and introduction of animal immunization policies by the government organizations in many developing nations such as China are likely to shift consumers from conventional treatments to advanced veterinary drugs.

Market size and forecast

The global veterinary drug market is predicted to flourish significantly at a CAGR of 6.8% over the forecast period i.e. 2016-2023. Moreover, the market of veterinary drug market accounted for USD 25.3 Billion in 2015 and the market is further anticipated to garner USD 49.8 Billion by 2023.

North America was accounted the largest market revenue share in 2015 in veterinary drug market across the globe. The market of North America region is expected to continue its dominance over the forecast period and predicted to account 31.5% share of revenue over the forecast period i.e. 2016-2023 owing to increasing gross disposable income of population which will leads to higher spending on animal healthcare. On the other hand, Europe is expected to be the second largest share contributor across the globe in the market of veterinary drug due to availability of cost-effective and advances veterinary drug in the market.

Moreover, the market of Asia-Pacific market of veterinary drug is estimated to fastest growing market over the forecast period. Rising initiatives towards animal healthcare and increasing adoption of medicated feed additives for livestock companions are some of the factors prompting the demand for veterinary drug in near future.

The livestock companion diseases are increasing burden which leads to an increase in animal healthcare expenditure. The nations facing economic issues are likely to adopt cost effective and efficient veterinary drugs in order to minimize the burden in terms of economic cost and decrease the animal healthcare expenditure. Further, emergence of pharmaceutical and biotech companies, huge investment in animal healthcare and rising initiatives from government authorities to develop cost effective and safe drugs in order to minimize the animal diseases burden in terms of animal suffering are some of the factors exhibit the positive growth of veterinary drugs in near future.

Market Segmentation

Our in-depth analysis segmented the global veterinary drug market in the following segments:

By Product

Drugs

• Anti-Invectives
• Anti-Inflammatory
• Parasiticides

Vaccines

• Inactivated vaccines
• Attenuated vaccines
• Recombinant vaccines

Medicated feed Additives

• Amino acids
• Antibiotics

By Route of administration

• Oral
• Parenteral
• Topical

By Animal Type

• Companion Animals (dogs, cats, horses, etc.)
• Livestock Animals (cattle, sheep, poultry, etc.)

By End-user

• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies and Drug stores

By Region

Global veterinary drug market is further classified on the basis of region as follows:

• North America (United States /U.S. & Canada)
• Latin America (Brazil, Mexico, Rest of Latin America)
• Western and Eastern Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Western Europe)
• Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia)
• Middle East and North Africa (MENA)
• Rest of World

Growth Drivers and challenges

Rise in number of pet ownership and increasing concern towards health and well-being of animals among the owners are some of the key elements which are expected to bolster the demand for veterinary drugs in near future.

In addition to this, factors such as introduction of cost-effective and efficient veterinary drugs, availability of numerous veterinary drugs for treatment of several diseases, rising drugs preferences by pet and poultry farm owners and increasing demand in research laboratories to deliver more effective drugs for the treatment of severe diseases are some of the key elements expected to prompt the demand for veterinary drugs over the forecast period i.e. 2016-2023.

However, increasing cost of animal healthcare, growing variety of diseases in animals, lack of awareness in undeveloped nations, requirement of huge expenditure for research and development of veterinary drugs are some of the factors likely to inhibit the growth of veterinary drugs market in near future.

Key Players

The key vendors of veterinary drug market are as follows:

• Bayer Animal Health
  •  Company Overview
  • Key Product Offerings
  • Business Strategy
  • SWOT Analysis
  • Financials
• Ceva Animal Healthcare

•  Elanco Animal Health
• Merck Ltd.
• Zoetis Animal Healthcare
• Virbac S.A.
• Merial Animal Health

Scope and Context

Overview of the Parent Market

Analyst View

Segmentation

The Global veterinary drug Market is segmented as follows:

• By Product type Market Size and Y-O-Y Growth Analysis
• By Route of Administration Market Size and Y-O-Y Growth Analysis
• By Animal type Market Size and Y-O-Y Growth Analysis
• By End-user Market Size and Y-O-Y Growth Analysis

By Regions

• North America (United States/U.S., Canada) Market Size and Y-O-Y Growth Analysis
• Latin America (Mexico, Brazil, Rest of Latin America) Market Size and Y-O-Y Growth Analysis
• Western and Eastern Europe (Germany, Italy, Spain, France, U.K, Benelux, Hungary, Rest Of Western Europe, Russia Poland, Rest of Eastern Europe) Market Size and Y-O-Y Growth Analysis
• Asia-Pacific (China, India, Singapore, Japan, Australia and New Zealand and Rest of Asia) Market Size and Y-O-Y Growth Analysis
• Middle East and North Africa (MENA) Market Size and Y-O-Y Growth Analysis
• Rest of World  Market Size and Y-O-Y Growth Analysis

Market Dynamics

Supply and Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment